Donepezil improves neuropathy through activation of AMPK signalling pathway in streptozotocin-induced diabetic mice
| Autor: | Norhan M. El-Sayed, Amal A.M. Ahmed, Mangreed M. Atef, Yasser M. Mostafa |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Male
0301 basic medicine Diabetic neuropathy Cell Cycle Proteins mTORC1 AMP-Activated Protein Kinases Pharmacology Receptors N-Methyl-D-Aspartate Biochemistry Neuroprotection Streptozocin Diabetes Mellitus Experimental Mice 03 medical and health sciences 0302 clinical medicine Diabetic Neuropathies medicine Animals Donepezil Eukaryotic Initiation Factors Protein kinase B Adaptor Proteins Signal Transducing Kinase business.industry AMPK Phosphoproteins medicine.disease Sciatic Nerve Enzyme Activation 030104 developmental biology Spinal Cord 030220 oncology & carcinogenesis Hyperalgesia Sciatic nerve Mitogen-Activated Protein Kinases medicine.symptom Carrier Proteins business Signal Transduction |
| Zdroj: | Biochemical Pharmacology. 159:1-10 |
| ISSN: | 0006-2952 |
| DOI: | 10.1016/j.bcp.2018.11.006 |
| Popis: | Diabetic neuropathy (DN) is a common complication of diabetes mellitus and is associated with structural changes in the nerves. However, the molecular basis for DN is poorly understood. Adenosine monophosphate activated protein kinase (AMPK) has been shown to regulate the activity of some kinases including protein kinase B (AKT), mitogen-activated protein kinases (MAPK) and mammalian target of rapamycin complex 1 (mTORC1) that represent important signalling pathways modulating the function of peripheral nociceptive neuron. Donepezil can activate AMPK and exerts neuroprotective effects. In this study, streptozotocin (45 mg/kg for 5 Day, i.p.) was used to induce experimental DN. After confirmation of development of neuropathy, mice were randomly distributed into five groups: Group 1; negative control group received saline (0.9%NaCl), Group 2; diabetic mice received saline, Group (3–5); diabetic mice received daily donepezil (1, 2 or 4 mg/kg, p.o.) respectively for 20 days. Mice were then sacrificed under anesthesia then their sciatic nerve and spinal cord were dissected out and processed for biochemical and histopathological studies. Diabetic mice revealed severe histological abnormalities including degenerated neurons in the spinal cord and swollen myelin sheath with inflammatory edema observed in sciatic nerves. In addition, diabetic mice showed reduced expression of p-AMPK in sciatic nerves with consequent activation of AKT/MAPK/4EBP1. A significant upregulation of the N-Methyl- d -aspartate (NMDA) receptors in both cervical and lumbar regions of spinal cord of diabetic mice was also demonstrated. Donepezil, an AMPK activator, blocked the phosphorylation of AKT/MAPK/4EBP1, down regulate the expression of NMDA receptors and reversed hyperalgesia developed in diabetic mice. Therefore, Donepezil could be a potential pharmacological agent for management of DN. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect